To investigate sex differences in immune-cell composition, gene expression, and genetic regulation using single-cell analysis, which may have implications for understanding autoimmune diseases.
Key Findings:
Men had higher proportions of CD14-positive monocytes, dendritic cells, natural killer cells, and various T cell types.
Women had higher proportions of B cells, CD4-positive naive T cells, and regulatory T cells.
78 sex-differentially expressed genes identified, with 65 female-biased and 16 male-biased genes.
Only 16 of the 78 genes were located on sex chromosomes, indicating autosomal regulation's role in immune sexual dimorphism.
Female-biased genes were enriched for pathways related to tumor necrosis factor alpha signaling and interferon gamma response.
Male-biased genes were enriched for ribosomal and RNA-processing functions.
Interpretation:
The findings suggest significant genetic regulatory associations contributing to immune differences between sexes, with implications for understanding autoimmune diseases.
Limitations:
Study limited to participants of European ancestry, affecting generalizability across diverse populations.
Hormonal and environmental factors not directly measured, which may influence immune responses.
Single time-point sampling may obscure dynamic immune variations related to circadian rhythms or hormonal fluctuations.
Conclusion:
The study highlights the potential for sexually dimorphic genes to vary in immune response, emphasizing the need for further research to explore the mechanisms underlying immune diseases.
Patients with gout who reached serum urate targets had modestly higher 5-year cardiovascular event-free survival, with associations strongest among high-risk patients
Meta-analysis favored tofacitinib for some rheumatoid arthritis outcomes, but high heterogeneity, dose-dependent effects, and JAK inhibitor safety concerns complicate interpretation.
